This protocol should ony be used to refer patients with no suspicion of cancer.
If there is a suspicion of cancer, the patient should be referred using the guidelines and protocols in the Lanarkshire Cancer Referral Centre
This protocol should ony be used to refer patients with no suspicion of cancer.
If there is a suspicion of cancer, the patient should be referred using the guidelines and protocols in the Lanarkshire Cancer Referral Centre
This is a dictation template to provide a reminder of the information required to complete the referral. The fields in red are mandatory and must be completed on the referral protocol.
Main Presenting Complaint: [Text – 98 character maximum]
Reason for Referral: [Text]
World Health Organisation Performance Scale
Using the following as a guide, please select the most appropriate answer to describe the patients general health:
Options:
Priority: Urgent Suspicion of Cancer
Date of Onset: [Date]
Will the patient accept any site for treatment:
Unexplained weight loss:
Unexplained iron deficiency anemia:
Family history of oesophago-gastric cancer in more than two first degree relatives:
Family history of familial adenomatous polyposis in any first degree relative:
Barrett’s oesophagus:
Pernicious anaemia:
Gastric surgery over 20 years ago:
Known dysplasia, atrophic gastritis, intestinal metaplasia:
Upper abdominal epigastric mass:
Iron deficiency anaemias:
Jaundice:
Upper abdominal mass:
FBC and ESR sent:
LFT, U&E sent:
Previous endoscopy done:
This is a dictation template to provide a reminder of the information required to complete the referral. The fields in red are mandatory and must be completed on the referral protocol.
Main Presenting Complaint: [Text – 98 character maximum]
Reason for Referral: [Text]
World Health Organisation Performance Scale
Using the following as a guide, please select the most appropriate answer to describe the patients general health:
Options:
Priority: Urgent Suspicion of Cancer
Date of Onset: [Date]
Will the patient accept any site for treatment:
Unexplained weight loss:
Unexplained iron deficiency anemia:
Family history of oesophago-gastric cancer in more than two first degree relatives:
Family history of familial adenomatous polyposis in any first degree relative:
Barrett’s oesophagus:
Pernicious anaemia:
Gastric surgery over 20 years ago:
Known dysplasia, atrophic gastritis, intestinal metaplasia:
Upper abdominal epigastric mass:
Iron deficiency anaemias:
Jaundice:
Upper abdominal mass:
FBC and ESR sent:
LFT, U&E sent:
Previous endoscopy done:
Approximately 3,000 people are diagnosed with a primary oesophago-gastric, hepatobiliary or pancreatic cancer in Scotland every year.
Common symptoms of oesophago-gastric cancer include weight loss, dysphagia, heartburn or pain, vomiting and anaemia. Common symptoms of hepatobiliary or pancreatic cancer include jaundice, abdominal mass, epigastric pain and weight loss. The risk of developing an oesophago-gastric cancer is higher in patients of East Asian origin and a higher suspicion of risk should be used in these patients.
An abdominal examination and appropriate blood tests (for example, full blood count, ferritin, urea and electrolytes test [U&Es] and liver function tests [LFTs]) should be performed on all patients with symptoms suggestive of these cancers. These findings can facilitate triage in secondary care. Referral should not be influenced by Helicobacter pylori (H pylori) status. Proton pump inhibitors should be avoided if possible prior to investigation. H2 antagonists may be used for symptomatic relief.
All patients with high-risk features should be referred to a team specialising in the management of oesophago-gastric, hepatobiliary or pancreatic cancers, depending on local arrangements.
Dysphagia (interference of the swallowing mechanism that occurs within 5 seconds of the swallowing process) or odynophagia (pain on swallowing) at any age.
New onset upper gastrointestinal pain or discomfort in people over 55 years.
New or worsening upper gastrointestinal pain or discomfort combined with one or more of the following features:
Persistent vomiting more than 4 weeks.
Upper gastrointestinal pain or discomfort combined with at least one of the following risk factors:
Features of hepatobiliary or pancreatic cancer can be vague and non-specific, and may include:
Dyspepsia under 55 years without accompanying symptoms or risk factors should be managed according to local or national guidelines.
There should be a low threshold for considering investigation (perhaps with discussion about appropriate imaging with a radiologist) or routine referral for patients presenting with:
Reference:
Scottish Referral Guidelines for Suspected Cancer. Scottish Government, August 2014
SIGN Guideline 87 – Management of oesophageal and gastric cancer
Clinical Lead Mr Hakim BenYounes, Chief of Medical Services, NHS Lanarkshire
Review Date March 2017
Approximately 3,000 people are diagnosed with a primary oesophago-gastric, hepatobiliary or pancreatic cancer in Scotland every year.
Common symptoms of oesophago-gastric cancer include weight loss, dysphagia, heartburn or pain, vomiting and anaemia. Common symptoms of hepatobiliary or pancreatic cancer include jaundice, abdominal mass, epigastric pain and weight loss. The risk of developing an oesophago-gastric cancer is higher in patients of East Asian origin and a higher suspicion of risk should be used in these patients.
An abdominal examination and appropriate blood tests (for example, full blood count, ferritin, urea and electrolytes test [U&Es] and liver function tests [LFTs]) should be performed on all patients with symptoms suggestive of these cancers. These findings can facilitate triage in secondary care. Referral should not be influenced by Helicobacter pylori (H pylori) status. Proton pump inhibitors should be avoided if possible prior to investigation. H2 antagonists may be used for symptomatic relief.
All patients with high-risk features should be referred to a team specialising in the management of oesophago-gastric, hepatobiliary or pancreatic cancers, depending on local arrangements.
Dysphagia (interference of the swallowing mechanism that occurs within 5 seconds of the swallowing process) or odynophagia (pain on swallowing) at any age.
New onset upper gastrointestinal pain or discomfort in people over 55 years.
New or worsening upper gastrointestinal pain or discomfort combined with one or more of the following features:
Persistent vomiting more than 4 weeks.
Upper gastrointestinal pain or discomfort combined with at least one of the following risk factors:
Features of hepatobiliary or pancreatic cancer can be vague and non-specific, and may include:
Dyspepsia under 55 years without accompanying symptoms or risk factors should be managed according to local or national guidelines.
There should be a low threshold for considering investigation (perhaps with discussion about appropriate imaging with a radiologist) or routine referral for patients presenting with:
Reference:
Scottish Referral Guidelines for Suspected Cancer. Scottish Government, August 2014
SIGN Guideline 87 – Management of oesophageal and gastric cancer
Clinical Lead Mr Hakim BenYounes, Chief of Medical Services, NHS Lanarkshire
Review Date March 2017
Gastro Intestinal (Upper) Cancer Endoscopy dictation template
Lower gastrointestinal symptoms are common presentations in primary care. Rectal bleeding for instance is estimated to affect 14,000 individuals per 100,000 population each year. There are large differences in the predictive value of rectal bleeding for cancer according to its association with other symptoms and signs and the age of the patient. For example, the positive predictive value of rectal bleeding alone is 2.4%, which rises to 8.5% in combination with an abnormal rectal examination.
Different management strategies should be adopted according to cancer risk so that those patients with transient lowrisk symptoms caused by benign disease avoid unnecessary investigation. The following guideline is recommended for managing patients with features associated with a possible diagnosis of colorectal cancer. Guidance for referral to regional genetics centres for those with a family history of colorectal cancer is available available at Scottish Government Health and Social Care website. In patients with ulcerative colitis, a plan for follow up should be agreed.
High-risk features Urgent suspicion of cancer referral | |
---|---|
Bleeding | Repeated rectal bleeding without an obvious anal cause Any blood mixed with the stool |
Bowel Habit | Persistent change in bowel habit especially to looser stools (more than 4 weeks) |
Mass | Right-sided abdominal mass Palpable rectal mass |
Iron deficiency anaemia In men of any age with unexplained iron deficiency anaemia and a haemoglobin of 11g/100ml or below. In non-menstruating women with unexplained iron deficiency anaemia and a haemoglobin of 10g/100ml or below. | Unexplained iron deficiency anaemia |
Other | Past history of lower gastrointestinal cancer with any of the symptoms above |
Low-risk features
Watch and wait (4 weeks)
Refer if symptoms persist or recur
Reference:
Scottish Referral Guidelines for Suspected Cancer. Scottish Government, August 2014
SIGN Guideline 126 – Diagnosis and Management of Colorectal Cancer
Lead Clinician Mr A Brown, NHS Lanarkshire
Review Date March 2017